Circulating Tumor DNA in Early Breast Cancer: What Breast Surgeons Need to Know
In this episode of SurgOnc Today, breast surgical oncologists explore circulating tumor DNA (ctDNA) in early-stage breast cancer and what breast surgeons need to know about this rapidly evolving biomarker. The panel explains what ctDNA is, how it is detected, and its emerging role in identifying molecular residual disease and assessing treatment response. They review the current evidence for ctDNA testing during neoadjuvant therapy, after surgery, and during surveillance, while highlighting important limitations in using ctDNA to guide treatment and surgical decision-making. The conversation…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.